MarketScreener Editorial Features Pardes Biosciences, Inc.
Equities
PRDS
US69945Q1058
MarketScreener Editorial Features
ANALYST RECOMMENDATIONS : Admiral, Hiscox, National Grid, Qiagen, Unilever... | January 17, 2022 at 06:12 am EST | |
MarketScreener’s World Press Review : January 13, 2022 | January 13, 2022 at 07:50 am EST |